RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Date:

November 19, 2024

President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services is one of several unorthodox appointments rolled out in recent weeks, and investors are scrambling to understand the move’s potential impact on markets.

Source link

Elixir, Securitize launch DeFi vaults for BlackRock’s BUIDL

Alameda County child believed to be latest case of bird flu; source unknown

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

RFK Jr. may start a food and drug ‘culture war.’ Investors are running for cover.

Recent posts

A Trump White House could see M&A uptick in these sectors

Mattel’s stock rallies on news of acquisition offer as Hasbro may enter the fray

Home Depot’s stock drops as higher rates hurt spending on home improvement

Disney’s slowing park attendance will weigh on the stock for the next 12 to 18 months, analysts say

Why solar is the fastest-growing source of U.S. electricity

Zillow’s stock surges as analyst says start buying as mortgage rates fall

Retiree healthcare costs jump almost 5% to $165,000 — more than double the 2002 rate

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Is gold’s record price run coming to an end? Here’s how to tell.

Oil prices on track for 4th straight weekly gain

Beyond AI, AMD and Intel earnings will hit on another important trend

Hint of ‘very high’ consumer inflation expectations raises risks for Treasury market

These stocks stand to benefit if a Trump White House adopts a tougher stance on China

Rivian’s stock rockets 41% higher on $1 billion Volkswagen investment, planned JV

Cava is riding a strong wave, but the stock’s quadrupling in 2024 has analysts wary

Related articles

Here’s what bond and gold traders are signaling about Russia’s nuclear shift

Stock market ‘finally paying more attention to tariffs’ as a potential headwind

Investors are bracing for higher-for-even-longer interest rates

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Manufacturing activity surges in New York region to highest level in nearly three years

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Company

Follow us